Ray Dalio's position in Neurocrine Biosciences is currently worth $3.12 Million. That's 0.02% of their equity portfolio (430th largest holding). The first Neurocrine Biosciences trade was made in Q2 2021. Since then Ray Dalio bought shares three more times and sold shares on six occasions. The stake costed the investor $2.45 Million, netting the investor a gain of 27% so far.